Journal of Virology · 2009 · 37 citations · 70 references
Life SciencesInfectious DiseasesMolecular BiologyCell SignalingSignal TransductionVirologyAntiviral ImmunityImmune Cell SignalingViral PathogenesisHerpesvirus ReactivationProtein Kinase A SignalingVasoactive Intestinal Peptide Signaling
The triggering mechanisms underlying reactivation of human cytomegalovirus (HCMV) in latently infected persons are unclear. During latency, HCMV major immediate-early (MIE) gene expression breaks silence to initiate viral reactivation. Using quiescently HCMV-infected human pluripotent embryonal NTera2 cells (NT2) to model HCMV reactivation, we show that vasoactive intestinal peptide (VIP), an immunomodulatory neuropeptide, immediately and dose-dependently (1 to 500 nM) activates HCMV MIE gene expression. This response requires the MIE enhancer cyclic AMP response elements (CRE). VIP quickly elevates CREB Ser133 and ATF-1 Ser63 phosphorylation levels, although the CREB Ser133 phosphorylation level is substantial at baseline. VIP does not change the level of HCMV genomes in nuclei, Oct4 (pluripotent cell marker), or hDaxx (cellular repressor of HCMV gene expression). VIP-activated MIE gene expression is mediated by cellular protein kinase A (PKA), CREB, and TORC2. VIP induces PKA-dependent TORC2 Ser171 dephosphorylation and nuclear entry, which likely enables MIE gene activation, as TORC2 S171A (devoid of Ser171 phosphorylation) exhibits enhanced nuclear entry and desilences the MIE genes in the absence of VIP stimulation. In conclusion, VIP stimulation of the PKA-CREB-TORC2 signaling cascade activates HCMV CRE-dependent MIE gene expression in quiescently infected NT2 cells. We speculate that neurohormonal stimulation via this signaling cascade is a possible means for reversing HCMV silence in vivo.
70
cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway
Mark Vossler, Hong Yao, Randall D. York et al. · Cell · 1997 · 1.1K citations · Full text
Xinmin Zhang, Duncan T. Odom, Seung‐Hoi Koo et al. · Proceedings of the National Academy of Sciences · 2005 · 1K citations
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Seung‐Hoi Koo, Lawrence Flechner, Ling Qi et al. · Nature · 2005 · 975 citations